Global Anti-tuberculosis Medicine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 111

Published Date: 10 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Anti-tuberculosis Medicine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Anti-tuberculosis Medicine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Anti-tuberculosis Medicine market size and forecasts, in consumption value ($ Million), sales quantity (Kiliton), and average selling prices (US$/Ton), 2018-2029
Global Anti-tuberculosis Medicine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kiliton), and average selling prices (US$/Ton), 2018-2029
Global Anti-tuberculosis Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kiliton), and average selling prices (US$/Ton), 2018-2029
Global Anti-tuberculosis Medicine market shares of main players, shipments in revenue ($ Million), sales quantity (Kiliton), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-tuberculosis Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-tuberculosis Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson and Pfizer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Anti-tuberculosis Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Isoniazid
    Rifampin
    Ethambutol
    Pyrazinamide
    Otherr

Market segment by Application
    Hospitals and Clinics
    Government Agencies
    Non-Profit Organizations
    Others

Major players covered
    Lupin
    Macleods Pharmaceuticals
    Otsuka Pharmaceutical
    Johnson & Johnson
    Pfizer
    Novartis
    Abbott
    AstraZeneca
    Bayer
    Eli Lilly
    GlaxoSmithKline
    Merck
    Sanofi
    Chongqing Huapont Pharm
    Shuangding Pharm
    Hongqi pharmaceutical

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-tuberculosis Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-tuberculosis Medicine, with price, sales, revenue and global market share of Anti-tuberculosis Medicine from 2018 to 2023.
Chapter 3, the Anti-tuberculosis Medicine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-tuberculosis Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Anti-tuberculosis Medicine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-tuberculosis Medicine.
Chapter 14 and 15, to describe Anti-tuberculosis Medicine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Anti-tuberculosis Medicine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Anti-tuberculosis Medicine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Isoniazid
        1.3.3 Rifampin
        1.3.4 Ethambutol
        1.3.5 Pyrazinamide
        1.3.6 Otherr
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Anti-tuberculosis Medicine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals and Clinics
        1.4.3 Government Agencies
        1.4.4 Non-Profit Organizations
        1.4.5 Others
    1.5 Global Anti-tuberculosis Medicine Market Size & Forecast
        1.5.1 Global Anti-tuberculosis Medicine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Anti-tuberculosis Medicine Sales Quantity (2018-2029)
        1.5.3 Global Anti-tuberculosis Medicine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Lupin
        2.1.1 Lupin Details
        2.1.2 Lupin Major Business
        2.1.3 Lupin Anti-tuberculosis Medicine Product and Services
        2.1.4 Lupin Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Lupin Recent Developments/Updates
    2.2 Macleods Pharmaceuticals
        2.2.1 Macleods Pharmaceuticals Details
        2.2.2 Macleods Pharmaceuticals Major Business
        2.2.3 Macleods Pharmaceuticals Anti-tuberculosis Medicine Product and Services
        2.2.4 Macleods Pharmaceuticals Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Macleods Pharmaceuticals Recent Developments/Updates
    2.3 Otsuka Pharmaceutical
        2.3.1 Otsuka Pharmaceutical Details
        2.3.2 Otsuka Pharmaceutical Major Business
        2.3.3 Otsuka Pharmaceutical Anti-tuberculosis Medicine Product and Services
        2.3.4 Otsuka Pharmaceutical Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Otsuka Pharmaceutical Recent Developments/Updates
    2.4 Johnson & Johnson
        2.4.1 Johnson & Johnson Details
        2.4.2 Johnson & Johnson Major Business
        2.4.3 Johnson & Johnson Anti-tuberculosis Medicine Product and Services
        2.4.4 Johnson & Johnson Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Johnson & Johnson Recent Developments/Updates
    2.5 Pfizer
        2.5.1 Pfizer Details
        2.5.2 Pfizer Major Business
        2.5.3 Pfizer Anti-tuberculosis Medicine Product and Services
        2.5.4 Pfizer Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Pfizer Recent Developments/Updates
    2.6 Novartis
        2.6.1 Novartis Details
        2.6.2 Novartis Major Business
        2.6.3 Novartis Anti-tuberculosis Medicine Product and Services
        2.6.4 Novartis Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Novartis Recent Developments/Updates
    2.7 Abbott
        2.7.1 Abbott Details
        2.7.2 Abbott Major Business
        2.7.3 Abbott Anti-tuberculosis Medicine Product and Services
        2.7.4 Abbott Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Abbott Recent Developments/Updates
    2.8 AstraZeneca
        2.8.1 AstraZeneca Details
        2.8.2 AstraZeneca Major Business
        2.8.3 AstraZeneca Anti-tuberculosis Medicine Product and Services
        2.8.4 AstraZeneca Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 AstraZeneca Recent Developments/Updates
    2.9 Bayer
        2.9.1 Bayer Details
        2.9.2 Bayer Major Business
        2.9.3 Bayer Anti-tuberculosis Medicine Product and Services
        2.9.4 Bayer Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Bayer Recent Developments/Updates
    2.10 Eli Lilly
        2.10.1 Eli Lilly Details
        2.10.2 Eli Lilly Major Business
        2.10.3 Eli Lilly Anti-tuberculosis Medicine Product and Services
        2.10.4 Eli Lilly Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Eli Lilly Recent Developments/Updates
    2.11 GlaxoSmithKline
        2.11.1 GlaxoSmithKline Details
        2.11.2 GlaxoSmithKline Major Business
        2.11.3 GlaxoSmithKline Anti-tuberculosis Medicine Product and Services
        2.11.4 GlaxoSmithKline Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 GlaxoSmithKline Recent Developments/Updates
    2.12 Merck
        2.12.1 Merck Details
        2.12.2 Merck Major Business
        2.12.3 Merck Anti-tuberculosis Medicine Product and Services
        2.12.4 Merck Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Merck Recent Developments/Updates
    2.13 Sanofi
        2.13.1 Sanofi Details
        2.13.2 Sanofi Major Business
        2.13.3 Sanofi Anti-tuberculosis Medicine Product and Services
        2.13.4 Sanofi Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Sanofi Recent Developments/Updates
    2.14 Chongqing Huapont Pharm
        2.14.1 Chongqing Huapont Pharm Details
        2.14.2 Chongqing Huapont Pharm Major Business
        2.14.3 Chongqing Huapont Pharm Anti-tuberculosis Medicine Product and Services
        2.14.4 Chongqing Huapont Pharm Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Chongqing Huapont Pharm Recent Developments/Updates
    2.15 Shuangding Pharm
        2.15.1 Shuangding Pharm Details
        2.15.2 Shuangding Pharm Major Business
        2.15.3 Shuangding Pharm Anti-tuberculosis Medicine Product and Services
        2.15.4 Shuangding Pharm Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Shuangding Pharm Recent Developments/Updates
    2.16 Hongqi pharmaceutical
        2.16.1 Hongqi pharmaceutical Details
        2.16.2 Hongqi pharmaceutical Major Business
        2.16.3 Hongqi pharmaceutical Anti-tuberculosis Medicine Product and Services
        2.16.4 Hongqi pharmaceutical Anti-tuberculosis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Hongqi pharmaceutical Recent Developments/Updates

3 Competitive Environment: Anti-tuberculosis Medicine by Manufacturer
    3.1 Global Anti-tuberculosis Medicine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Anti-tuberculosis Medicine Revenue by Manufacturer (2018-2023)
    3.3 Global Anti-tuberculosis Medicine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Anti-tuberculosis Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Anti-tuberculosis Medicine Manufacturer Market Share in 2022
        3.4.2 Top 6 Anti-tuberculosis Medicine Manufacturer Market Share in 2022
    3.5 Anti-tuberculosis Medicine Market: Overall Company Footprint Analysis
        3.5.1 Anti-tuberculosis Medicine Market: Region Footprint
        3.5.2 Anti-tuberculosis Medicine Market: Company Product Type Footprint
        3.5.3 Anti-tuberculosis Medicine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Anti-tuberculosis Medicine Market Size by Region
        4.1.1 Global Anti-tuberculosis Medicine Sales Quantity by Region (2018-2029)
        4.1.2 Global Anti-tuberculosis Medicine Consumption Value by Region (2018-2029)
        4.1.3 Global Anti-tuberculosis Medicine Average Price by Region (2018-2029)
    4.2 North America Anti-tuberculosis Medicine Consumption Value (2018-2029)
    4.3 Europe Anti-tuberculosis Medicine Consumption Value (2018-2029)
    4.4 Asia-Pacific Anti-tuberculosis Medicine Consumption Value (2018-2029)
    4.5 South America Anti-tuberculosis Medicine Consumption Value (2018-2029)
    4.6 Middle East and Africa Anti-tuberculosis Medicine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Anti-tuberculosis Medicine Sales Quantity by Type (2018-2029)
    5.2 Global Anti-tuberculosis Medicine Consumption Value by Type (2018-2029)
    5.3 Global Anti-tuberculosis Medicine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Anti-tuberculosis Medicine Sales Quantity by Application (2018-2029)
    6.2 Global Anti-tuberculosis Medicine Consumption Value by Application (2018-2029)
    6.3 Global Anti-tuberculosis Medicine Average Price by Application (2018-2029)

7 North America
    7.1 North America Anti-tuberculosis Medicine Sales Quantity by Type (2018-2029)
    7.2 North America Anti-tuberculosis Medicine Sales Quantity by Application (2018-2029)
    7.3 North America Anti-tuberculosis Medicine Market Size by Country
        7.3.1 North America Anti-tuberculosis Medicine Sales Quantity by Country (2018-2029)
        7.3.2 North America Anti-tuberculosis Medicine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Anti-tuberculosis Medicine Sales Quantity by Type (2018-2029)
    8.2 Europe Anti-tuberculosis Medicine Sales Quantity by Application (2018-2029)
    8.3 Europe Anti-tuberculosis Medicine Market Size by Country
        8.3.1 Europe Anti-tuberculosis Medicine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Anti-tuberculosis Medicine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Anti-tuberculosis Medicine Market Size by Region
        9.3.1 Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Anti-tuberculosis Medicine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Anti-tuberculosis Medicine Sales Quantity by Type (2018-2029)
    10.2 South America Anti-tuberculosis Medicine Sales Quantity by Application (2018-2029)
    10.3 South America Anti-tuberculosis Medicine Market Size by Country
        10.3.1 South America Anti-tuberculosis Medicine Sales Quantity by Country (2018-2029)
        10.3.2 South America Anti-tuberculosis Medicine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Anti-tuberculosis Medicine Market Size by Country
        11.3.1 Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Anti-tuberculosis Medicine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Anti-tuberculosis Medicine Market Drivers
    12.2 Anti-tuberculosis Medicine Market Restraints
    12.3 Anti-tuberculosis Medicine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Anti-tuberculosis Medicine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Anti-tuberculosis Medicine
    13.3 Anti-tuberculosis Medicine Production Process
    13.4 Anti-tuberculosis Medicine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Anti-tuberculosis Medicine Typical Distributors
    14.3 Anti-tuberculosis Medicine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Anti-tuberculosis Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Anti-tuberculosis Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Lupin Basic Information, Manufacturing Base and Competitors
    Table 4. Lupin Major Business
    Table 5. Lupin Anti-tuberculosis Medicine Product and Services
    Table 6. Lupin Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Lupin Recent Developments/Updates
    Table 8. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 9. Macleods Pharmaceuticals Major Business
    Table 10. Macleods Pharmaceuticals Anti-tuberculosis Medicine Product and Services
    Table 11. Macleods Pharmaceuticals Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Macleods Pharmaceuticals Recent Developments/Updates
    Table 13. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 14. Otsuka Pharmaceutical Major Business
    Table 15. Otsuka Pharmaceutical Anti-tuberculosis Medicine Product and Services
    Table 16. Otsuka Pharmaceutical Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Otsuka Pharmaceutical Recent Developments/Updates
    Table 18. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 19. Johnson & Johnson Major Business
    Table 20. Johnson & Johnson Anti-tuberculosis Medicine Product and Services
    Table 21. Johnson & Johnson Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Johnson & Johnson Recent Developments/Updates
    Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 24. Pfizer Major Business
    Table 25. Pfizer Anti-tuberculosis Medicine Product and Services
    Table 26. Pfizer Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Pfizer Recent Developments/Updates
    Table 28. Novartis Basic Information, Manufacturing Base and Competitors
    Table 29. Novartis Major Business
    Table 30. Novartis Anti-tuberculosis Medicine Product and Services
    Table 31. Novartis Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Novartis Recent Developments/Updates
    Table 33. Abbott Basic Information, Manufacturing Base and Competitors
    Table 34. Abbott Major Business
    Table 35. Abbott Anti-tuberculosis Medicine Product and Services
    Table 36. Abbott Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Abbott Recent Developments/Updates
    Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 39. AstraZeneca Major Business
    Table 40. AstraZeneca Anti-tuberculosis Medicine Product and Services
    Table 41. AstraZeneca Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. AstraZeneca Recent Developments/Updates
    Table 43. Bayer Basic Information, Manufacturing Base and Competitors
    Table 44. Bayer Major Business
    Table 45. Bayer Anti-tuberculosis Medicine Product and Services
    Table 46. Bayer Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Bayer Recent Developments/Updates
    Table 48. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 49. Eli Lilly Major Business
    Table 50. Eli Lilly Anti-tuberculosis Medicine Product and Services
    Table 51. Eli Lilly Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Eli Lilly Recent Developments/Updates
    Table 53. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 54. GlaxoSmithKline Major Business
    Table 55. GlaxoSmithKline Anti-tuberculosis Medicine Product and Services
    Table 56. GlaxoSmithKline Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. GlaxoSmithKline Recent Developments/Updates
    Table 58. Merck Basic Information, Manufacturing Base and Competitors
    Table 59. Merck Major Business
    Table 60. Merck Anti-tuberculosis Medicine Product and Services
    Table 61. Merck Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Merck Recent Developments/Updates
    Table 63. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 64. Sanofi Major Business
    Table 65. Sanofi Anti-tuberculosis Medicine Product and Services
    Table 66. Sanofi Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Sanofi Recent Developments/Updates
    Table 68. Chongqing Huapont Pharm Basic Information, Manufacturing Base and Competitors
    Table 69. Chongqing Huapont Pharm Major Business
    Table 70. Chongqing Huapont Pharm Anti-tuberculosis Medicine Product and Services
    Table 71. Chongqing Huapont Pharm Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Chongqing Huapont Pharm Recent Developments/Updates
    Table 73. Shuangding Pharm Basic Information, Manufacturing Base and Competitors
    Table 74. Shuangding Pharm Major Business
    Table 75. Shuangding Pharm Anti-tuberculosis Medicine Product and Services
    Table 76. Shuangding Pharm Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Shuangding Pharm Recent Developments/Updates
    Table 78. Hongqi pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 79. Hongqi pharmaceutical Major Business
    Table 80. Hongqi pharmaceutical Anti-tuberculosis Medicine Product and Services
    Table 81. Hongqi pharmaceutical Anti-tuberculosis Medicine Sales Quantity (Kiliton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 82. Hongqi pharmaceutical Recent Developments/Updates
    Table 83. Global Anti-tuberculosis Medicine Sales Quantity by Manufacturer (2018-2023) & (Kiliton)
    Table 84. Global Anti-tuberculosis Medicine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 85. Global Anti-tuberculosis Medicine Average Price by Manufacturer (2018-2023) & (US$/Ton)
    Table 86. Market Position of Manufacturers in Anti-tuberculosis Medicine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 87. Head Office and Anti-tuberculosis Medicine Production Site of Key Manufacturer
    Table 88. Anti-tuberculosis Medicine Market: Company Product Type Footprint
    Table 89. Anti-tuberculosis Medicine Market: Company Product Application Footprint
    Table 90. Anti-tuberculosis Medicine New Market Entrants and Barriers to Market Entry
    Table 91. Anti-tuberculosis Medicine Mergers, Acquisition, Agreements, and Collaborations
    Table 92. Global Anti-tuberculosis Medicine Sales Quantity by Region (2018-2023) & (Kiliton)
    Table 93. Global Anti-tuberculosis Medicine Sales Quantity by Region (2024-2029) & (Kiliton)
    Table 94. Global Anti-tuberculosis Medicine Consumption Value by Region (2018-2023) & (USD Million)
    Table 95. Global Anti-tuberculosis Medicine Consumption Value by Region (2024-2029) & (USD Million)
    Table 96. Global Anti-tuberculosis Medicine Average Price by Region (2018-2023) & (US$/Ton)
    Table 97. Global Anti-tuberculosis Medicine Average Price by Region (2024-2029) & (US$/Ton)
    Table 98. Global Anti-tuberculosis Medicine Sales Quantity by Type (2018-2023) & (Kiliton)
    Table 99. Global Anti-tuberculosis Medicine Sales Quantity by Type (2024-2029) & (Kiliton)
    Table 100. Global Anti-tuberculosis Medicine Consumption Value by Type (2018-2023) & (USD Million)
    Table 101. Global Anti-tuberculosis Medicine Consumption Value by Type (2024-2029) & (USD Million)
    Table 102. Global Anti-tuberculosis Medicine Average Price by Type (2018-2023) & (US$/Ton)
    Table 103. Global Anti-tuberculosis Medicine Average Price by Type (2024-2029) & (US$/Ton)
    Table 104. Global Anti-tuberculosis Medicine Sales Quantity by Application (2018-2023) & (Kiliton)
    Table 105. Global Anti-tuberculosis Medicine Sales Quantity by Application (2024-2029) & (Kiliton)
    Table 106. Global Anti-tuberculosis Medicine Consumption Value by Application (2018-2023) & (USD Million)
    Table 107. Global Anti-tuberculosis Medicine Consumption Value by Application (2024-2029) & (USD Million)
    Table 108. Global Anti-tuberculosis Medicine Average Price by Application (2018-2023) & (US$/Ton)
    Table 109. Global Anti-tuberculosis Medicine Average Price by Application (2024-2029) & (US$/Ton)
    Table 110. North America Anti-tuberculosis Medicine Sales Quantity by Type (2018-2023) & (Kiliton)
    Table 111. North America Anti-tuberculosis Medicine Sales Quantity by Type (2024-2029) & (Kiliton)
    Table 112. North America Anti-tuberculosis Medicine Sales Quantity by Application (2018-2023) & (Kiliton)
    Table 113. North America Anti-tuberculosis Medicine Sales Quantity by Application (2024-2029) & (Kiliton)
    Table 114. North America Anti-tuberculosis Medicine Sales Quantity by Country (2018-2023) & (Kiliton)
    Table 115. North America Anti-tuberculosis Medicine Sales Quantity by Country (2024-2029) & (Kiliton)
    Table 116. North America Anti-tuberculosis Medicine Consumption Value by Country (2018-2023) & (USD Million)
    Table 117. North America Anti-tuberculosis Medicine Consumption Value by Country (2024-2029) & (USD Million)
    Table 118. Europe Anti-tuberculosis Medicine Sales Quantity by Type (2018-2023) & (Kiliton)
    Table 119. Europe Anti-tuberculosis Medicine Sales Quantity by Type (2024-2029) & (Kiliton)
    Table 120. Europe Anti-tuberculosis Medicine Sales Quantity by Application (2018-2023) & (Kiliton)
    Table 121. Europe Anti-tuberculosis Medicine Sales Quantity by Application (2024-2029) & (Kiliton)
    Table 122. Europe Anti-tuberculosis Medicine Sales Quantity by Country (2018-2023) & (Kiliton)
    Table 123. Europe Anti-tuberculosis Medicine Sales Quantity by Country (2024-2029) & (Kiliton)
    Table 124. Europe Anti-tuberculosis Medicine Consumption Value by Country (2018-2023) & (USD Million)
    Table 125. Europe Anti-tuberculosis Medicine Consumption Value by Country (2024-2029) & (USD Million)
    Table 126. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Type (2018-2023) & (Kiliton)
    Table 127. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Type (2024-2029) & (Kiliton)
    Table 128. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Application (2018-2023) & (Kiliton)
    Table 129. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Application (2024-2029) & (Kiliton)
    Table 130. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Region (2018-2023) & (Kiliton)
    Table 131. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity by Region (2024-2029) & (Kiliton)
    Table 132. Asia-Pacific Anti-tuberculosis Medicine Consumption Value by Region (2018-2023) & (USD Million)
    Table 133. Asia-Pacific Anti-tuberculosis Medicine Consumption Value by Region (2024-2029) & (USD Million)
    Table 134. South America Anti-tuberculosis Medicine Sales Quantity by Type (2018-2023) & (Kiliton)
    Table 135. South America Anti-tuberculosis Medicine Sales Quantity by Type (2024-2029) & (Kiliton)
    Table 136. South America Anti-tuberculosis Medicine Sales Quantity by Application (2018-2023) & (Kiliton)
    Table 137. South America Anti-tuberculosis Medicine Sales Quantity by Application (2024-2029) & (Kiliton)
    Table 138. South America Anti-tuberculosis Medicine Sales Quantity by Country (2018-2023) & (Kiliton)
    Table 139. South America Anti-tuberculosis Medicine Sales Quantity by Country (2024-2029) & (Kiliton)
    Table 140. South America Anti-tuberculosis Medicine Consumption Value by Country (2018-2023) & (USD Million)
    Table 141. South America Anti-tuberculosis Medicine Consumption Value by Country (2024-2029) & (USD Million)
    Table 142. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Type (2018-2023) & (Kiliton)
    Table 143. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Type (2024-2029) & (Kiliton)
    Table 144. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Application (2018-2023) & (Kiliton)
    Table 145. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Application (2024-2029) & (Kiliton)
    Table 146. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Region (2018-2023) & (Kiliton)
    Table 147. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity by Region (2024-2029) & (Kiliton)
    Table 148. Middle East & Africa Anti-tuberculosis Medicine Consumption Value by Region (2018-2023) & (USD Million)
    Table 149. Middle East & Africa Anti-tuberculosis Medicine Consumption Value by Region (2024-2029) & (USD Million)
    Table 150. Anti-tuberculosis Medicine Raw Material
    Table 151. Key Manufacturers of Anti-tuberculosis Medicine Raw Materials
    Table 152. Anti-tuberculosis Medicine Typical Distributors
    Table 153. Anti-tuberculosis Medicine Typical Customers
List of Figures
    Figure 1. Anti-tuberculosis Medicine Picture
    Figure 2. Global Anti-tuberculosis Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Anti-tuberculosis Medicine Consumption Value Market Share by Type in 2022
    Figure 4. Isoniazid Examples
    Figure 5. Rifampin Examples
    Figure 6. Ethambutol Examples
    Figure 7. Pyrazinamide Examples
    Figure 8. Otherr Examples
    Figure 9. Global Anti-tuberculosis Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 10. Global Anti-tuberculosis Medicine Consumption Value Market Share by Application in 2022
    Figure 11. Hospitals and Clinics Examples
    Figure 12. Government Agencies Examples
    Figure 13. Non-Profit Organizations Examples
    Figure 14. Others Examples
    Figure 15. Global Anti-tuberculosis Medicine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 16. Global Anti-tuberculosis Medicine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 17. Global Anti-tuberculosis Medicine Sales Quantity (2018-2029) & (Kiliton)
    Figure 18. Global Anti-tuberculosis Medicine Average Price (2018-2029) & (US$/Ton)
    Figure 19. Global Anti-tuberculosis Medicine Sales Quantity Market Share by Manufacturer in 2022
    Figure 20. Global Anti-tuberculosis Medicine Consumption Value Market Share by Manufacturer in 2022
    Figure 21. Producer Shipments of Anti-tuberculosis Medicine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 22. Top 3 Anti-tuberculosis Medicine Manufacturer (Consumption Value) Market Share in 2022
    Figure 23. Top 6 Anti-tuberculosis Medicine Manufacturer (Consumption Value) Market Share in 2022
    Figure 24. Global Anti-tuberculosis Medicine Sales Quantity Market Share by Region (2018-2029)
    Figure 25. Global Anti-tuberculosis Medicine Consumption Value Market Share by Region (2018-2029)
    Figure 26. North America Anti-tuberculosis Medicine Consumption Value (2018-2029) & (USD Million)
    Figure 27. Europe Anti-tuberculosis Medicine Consumption Value (2018-2029) & (USD Million)
    Figure 28. Asia-Pacific Anti-tuberculosis Medicine Consumption Value (2018-2029) & (USD Million)
    Figure 29. South America Anti-tuberculosis Medicine Consumption Value (2018-2029) & (USD Million)
    Figure 30. Middle East & Africa Anti-tuberculosis Medicine Consumption Value (2018-2029) & (USD Million)
    Figure 31. Global Anti-tuberculosis Medicine Sales Quantity Market Share by Type (2018-2029)
    Figure 32. Global Anti-tuberculosis Medicine Consumption Value Market Share by Type (2018-2029)
    Figure 33. Global Anti-tuberculosis Medicine Average Price by Type (2018-2029) & (US$/Ton)
    Figure 34. Global Anti-tuberculosis Medicine Sales Quantity Market Share by Application (2018-2029)
    Figure 35. Global Anti-tuberculosis Medicine Consumption Value Market Share by Application (2018-2029)
    Figure 36. Global Anti-tuberculosis Medicine Average Price by Application (2018-2029) & (US$/Ton)
    Figure 37. North America Anti-tuberculosis Medicine Sales Quantity Market Share by Type (2018-2029)
    Figure 38. North America Anti-tuberculosis Medicine Sales Quantity Market Share by Application (2018-2029)
    Figure 39. North America Anti-tuberculosis Medicine Sales Quantity Market Share by Country (2018-2029)
    Figure 40. North America Anti-tuberculosis Medicine Consumption Value Market Share by Country (2018-2029)
    Figure 41. United States Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Canada Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 43. Mexico Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 44. Europe Anti-tuberculosis Medicine Sales Quantity Market Share by Type (2018-2029)
    Figure 45. Europe Anti-tuberculosis Medicine Sales Quantity Market Share by Application (2018-2029)
    Figure 46. Europe Anti-tuberculosis Medicine Sales Quantity Market Share by Country (2018-2029)
    Figure 47. Europe Anti-tuberculosis Medicine Consumption Value Market Share by Country (2018-2029)
    Figure 48. Germany Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. France Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. United Kingdom Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Russia Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 52. Italy Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 53. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity Market Share by Type (2018-2029)
    Figure 54. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity Market Share by Application (2018-2029)
    Figure 55. Asia-Pacific Anti-tuberculosis Medicine Sales Quantity Market Share by Region (2018-2029)
    Figure 56. Asia-Pacific Anti-tuberculosis Medicine Consumption Value Market Share by Region (2018-2029)
    Figure 57. China Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Japan Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Korea Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. India Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. Southeast Asia Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 62. Australia Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 63. South America Anti-tuberculosis Medicine Sales Quantity Market Share by Type (2018-2029)
    Figure 64. South America Anti-tuberculosis Medicine Sales Quantity Market Share by Application (2018-2029)
    Figure 65. South America Anti-tuberculosis Medicine Sales Quantity Market Share by Country (2018-2029)
    Figure 66. South America Anti-tuberculosis Medicine Consumption Value Market Share by Country (2018-2029)
    Figure 67. Brazil Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 68. Argentina Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 69. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity Market Share by Type (2018-2029)
    Figure 70. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity Market Share by Application (2018-2029)
    Figure 71. Middle East & Africa Anti-tuberculosis Medicine Sales Quantity Market Share by Region (2018-2029)
    Figure 72. Middle East & Africa Anti-tuberculosis Medicine Consumption Value Market Share by Region (2018-2029)
    Figure 73. Turkey Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Egypt Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. Saudi Arabia Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 76. South Africa Anti-tuberculosis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 77. Anti-tuberculosis Medicine Market Drivers
    Figure 78. Anti-tuberculosis Medicine Market Restraints
    Figure 79. Anti-tuberculosis Medicine Market Trends
    Figure 80. Porters Five Forces Analysis
    Figure 81. Manufacturing Cost Structure Analysis of Anti-tuberculosis Medicine in 2022
    Figure 82. Manufacturing Process Analysis of Anti-tuberculosis Medicine
    Figure 83. Anti-tuberculosis Medicine Industrial Chain
    Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 85. Direct Channel Pros & Cons
    Figure 86. Indirect Channel Pros & Cons
    Figure 87. Methodology
    Figure 88. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline
Merck
Sanofi
Chongqing Huapont Pharm
Shuangding Pharm
Hongqi pharmaceutical

Related Reports

Global Anti-tuberculosis Medicine Supply, Demand and Key Producers, 2023-2029

Global Anti-tuberculosis Medicine Supply, Demand and Key Producers, 2023-2029

date 04 Feb 2023

date Pharma & Healthcare

The global Anti-tuberculosis Medicine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Anti-tuberculosis Medicine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Anti-tuberculosis Medicine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Anti-tuberculosis Medicine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Anti-tuberculosis Medicine Supply, Demand and Key Producers, 2024-2030

Global Anti-tuberculosis Medicine Supply, Demand and Key Producers, 2024-2030

date 12 Feb 2024

date Pharma & Healthcare

The global Anti-tuberculosis Medicine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Anti-tuberculosis Medicine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>